retatrutide fat loss clinical trial results A new weight-loss drug called is generating excitement after participants lost an average of 30% of their body weight, that rival or even exceed weight-loss surgery. Researchers also retatrutide triple hormone receptor agonist
Description
Compounded semaglutide is typically injected subcutaneously once per week, following the same dose escalation schedule as the brand-name versions
This is just one example of the fascinating cascading benefits of GLP1s+ in terms of treatment expansion
Gut microbiota, enteroendocrine functions and metabolism

2024;DOI:10.1001/jamainternmed.2024.466.

None of this means you are destined to lose progress

Thanks to the many people who spoke to me in the last few months including Ebele Ola, Mathilde MERLET, Khalid Bhatti, Michel Robidoux, Thomas Digby, Dave S., Kyle Zien, Brett Belchetz, and many many more